已收盘 10-13 16:00:00 美东时间
0.000
0.00%
Covetrus (NASDAQ:CVET – Get Rating) is scheduled to be announcing its earnings ...
2022-07-29 21:13
Covetrus, Inc. (NASDAQ:CVET – Get Rating) has been given a consensus recommenda...
2022-07-26 15:11
Covetrus, Inc. (NASDAQ:CVET – Get Rating) saw a large growth in short interest ...
2022-07-20 19:41
Covetrus, Inc. (NASDAQ:CVET – Get Rating) CEO Benjamin Wolin sold 5,293 shares ...
2022-07-17 17:21
NEW YORK, NY / ACCESSWIRE / June 21, 2022 / Lifshitz Law Firm, P.C.: 纽约,NY...
2022-06-22 08:15
NEW YORK, NY / ACCESSWIRE / June 15, 2022 / Lifshitz Law Firm, P.C.: 纽约,NY...
2022-06-16 08:22
NEW YORK, June 1, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing pa...
2022-06-01 16:25
Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.
2022-05-25 22:13
Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Cap...
2022-05-25 21:48